GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001816 | Cytokine production |
| Process | GO:0001817 | Regulation of cytokine production |
| Process | GO:0001818 | Negative regulation of cytokine production |
| Process | GO:0006508 | Proteolysis |
| Process | GO:0006511 | Ubiquitin-dependent protein catabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0006996 | Organelle organization |
| Process | GO:0007010 | Cytoskeleton organization |
| Process | GO:0007015 | Actin filament organization |
| Process | GO:0007049 | Cell cycle |
| Process | GO:0007155 | Cell adhesion |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0009056 | Catabolic process |
| Process | GO:0009057 | Macromolecule catabolic process |
| Process | GO:0009892 | Negative regulation of metabolic process |
| Process | GO:0009966 | Regulation of signal transduction |
| Process | GO:0009968 | Negative regulation of signal transduction |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010467 | Gene expression |
| Process | GO:0010468 | Regulation of gene expression |
| Process | GO:0010498 | Proteasomal protein catabolic process |
| Process | GO:0010605 | Negative regulation of macromolecule metabolic process |
| Process | GO:0010629 | Negative regulation of gene expression |
| Process | GO:0010646 | Regulation of cell communication |
| Process | GO:0010648 | Negative regulation of cell communication |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016050 | Vesicle organization |
| Process | GO:0016477 | Cell migration |
| Process | GO:0019222 | Regulation of metabolic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019941 | Modification-dependent protein catabolic process |
| Process | GO:0023051 | Regulation of signaling |
| Process | GO:0023057 | Negative regulation of signaling |
| Process | GO:0030029 | Actin filament-based process |
| Process | GO:0030036 | Actin cytoskeleton organization |
| Process | GO:0030100 | Regulation of endocytosis |
| Process | GO:0030163 | Protein catabolic process |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032880 | Regulation of protein localization |
| Process | GO:0032905 | Transforming growth factor beta1 production |
| Process | GO:0032908 | Regulation of transforming growth factor beta1 production |
| Process | GO:0032911 | Negative regulation of transforming growth factor beta1 production |
| Process | GO:0032956 | Regulation of actin cytoskeleton organization |
| Process | GO:0032970 | Regulation of actin filament-based process |
| Process | GO:0033043 | Regulation of organelle organization |
| Process | GO:0043161 | Proteasome-mediated ubiquitin-dependent protein catabolic process |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043632 | Modification-dependent macromolecule catabolic process |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044248 | Cellular catabolic process |
| Process | GO:0044260 | Cellular macromolecule metabolic process |
| Process | GO:0044265 | Cellular macromolecule catabolic process |
| Process | GO:0048259 | Regulation of receptor-mediated endocytosis |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048519 | Negative regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048523 | Negative regulation of cellular process |
| Process | GO:0048583 | Regulation of response to stimulus |
| Process | GO:0048585 | Negative regulation of response to stimulus |
| Process | GO:0048870 | Cell motility |
| Process | GO:0050708 | Regulation of protein secretion |
| Process | GO:0050714 | Positive regulation of protein secretion |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0051046 | Regulation of secretion |
| Process | GO:0051047 | Positive regulation of secretion |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051050 | Positive regulation of transport |
| Process | GO:0051056 | Regulation of small GTPase mediated signal transduction |
| Process | GO:0051058 | Negative regulation of small GTPase mediated signal transduction |
| Process | GO:0051128 | Regulation of cellular component organization |
| Process | GO:0051222 | Positive regulation of protein transport |
| Process | GO:0051223 | Regulation of protein transport |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051241 | Negative regulation of multicellular organismal process |
| Process | GO:0051301 | Cell division |
| Process | GO:0051493 | Regulation of cytoskeleton organization |
| Process | GO:0051603 | Proteolysis involved in protein catabolic process |
| Process | GO:0060255 | Regulation of macromolecule metabolic process |
| Process | GO:0060341 | Regulation of cellular localization |
| Process | GO:0060627 | Regulation of vesicle-mediated transport |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0070201 | Regulation of establishment of protein localization |
| Process | GO:0071604 | Transforming growth factor beta production |
| Process | GO:0071634 | Regulation of transforming growth factor beta production |
| Process | GO:0071635 | Negative regulation of transforming growth factor beta production |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0097435 | Supramolecular fiber organization |
| Process | GO:0098609 | Cell-cell adhesion |
| Process | GO:1900180 | Regulation of protein localization to nucleus |
| Process | GO:1900182 | Positive regulation of protein localization to nucleus |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901565 | Organonitrogen compound catabolic process |
| Process | GO:1901575 | Organic substance catabolic process |
| Process | GO:1902531 | Regulation of intracellular signal transduction |
| Process | GO:1902532 | Negative regulation of intracellular signal transduction |
| Process | GO:1903530 | Regulation of secretion by cell |
| Process | GO:1903532 | Positive regulation of secretion by cell |
| Process | GO:1903829 | Positive regulation of protein localization |
| Process | GO:1904951 | Positive regulation of establishment of protein localization |
| Process | GO:2000249 | Regulation of actin cytoskeleton reorganization |
| Component | GO:0001650 | Fibrillar center |
| Component | GO:0001726 | Ruffle |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005730 | Nucleolus |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005813 | Centrosome |
| Component | GO:0005815 | Microtubule organizing center |
| Component | GO:0005856 | Cytoskeleton |
| Component | GO:0005884 | Actin filament |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005911 | Cell-cell junction |
| Component | GO:0015629 | Actin cytoskeleton |
| Component | GO:0015630 | Microtubule cytoskeleton |
| Component | GO:0016020 | Membrane |
| Component | GO:0030054 | Cell junction |
| Component | GO:0030139 | Endocytic vesicle |
| Component | GO:0030424 | Axon |
| Component | GO:0030425 | Dendrite |
| Component | GO:0031252 | Cell leading edge |
| Component | GO:0031410 | Cytoplasmic vesicle |
| Component | GO:0031941 | Filamentous actin |
| Component | GO:0031974 | Membrane-enclosed lumen |
| Component | GO:0031981 | Nuclear lumen |
| Component | GO:0031982 | Vesicle |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0034451 | Centriolar satellite |
| Component | GO:0036477 | Somatodendritic compartment |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043005 | Neuron projection |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0043233 | Organelle lumen |
| Component | GO:0048471 | Perinuclear region of cytoplasm |
| Component | GO:0070013 | Intracellular organelle lumen |
| Component | GO:0070161 | Anchoring junction |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097447 | Dendritic tree |
| Component | GO:0097708 | Intracellular vesicle |
| Component | GO:0099080 | Supramolecular complex |
| Component | GO:0099081 | Supramolecular polymer |
| Component | GO:0099512 | Supramolecular fiber |
| Component | GO:0099513 | Polymeric cytoskeletal fiber |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Function | GO:0005102 | Signaling receptor binding |
| Function | GO:0005126 | Cytokine receptor binding |
| Function | GO:0005172 | Vascular endothelial growth factor receptor binding |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0008013 | Beta-catenin binding |
| Function | GO:0008022 | Protein C-terminus binding |
| Function | GO:0017124 | SH3 domain binding |
| Function | GO:0019904 | Protein domain specific binding |
| Function | GO:0042802 | Identical protein binding |
| Function | GO:0044877 | Protein-containing complex binding |
| Function | GO:0045296 | Cadherin binding |
| Function | GO:0050839 | Cell adhesion molecule binding |
| Function | GO:0070851 | Growth factor receptor binding |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| KEGG | rno05100 | Bacterial invasion of epithelial cells |
Expression profile of Cd2ap in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 7.86609 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 7.7590837 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 7.6712008 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 7.6443005 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 7.945684 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 8.465907 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 8.105141 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 8.149491 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 8.041982 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 7.49279 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 7.7622004 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 7.7154055 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 7.447189 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 7.999748 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 7.2637696 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 7.379063 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 7.3750935 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 7.4581637 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 8.042308 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 7.56365 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 7.3193455 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 7.048702 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 7.4765577 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 7.2205296 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.247309623 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.567311308 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.573313648 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.719877486 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.394543146 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 6.945805959 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1790.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1403.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1738.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1333.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1263.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1248.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1351.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 2997.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1029.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1260.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1027.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1673.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 771.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 743.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 1099.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 742.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.049442 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.841812 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 7.747794 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.45233 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 7.943896 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.026962 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 23.024 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 22.254 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 27.428 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 18.874 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 16.992 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 9.67392 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 9.60756 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 8.5535 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 8.90419 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 10.1583 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 10.0498 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 9.8479 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 10.1087 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 8.7549 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 9.39855 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 7.60347 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 8.41277 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 9.67208 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 9.19953 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 9.01001 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 9.0295 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 132.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 130.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 167.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 197.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 180.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 125.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 176.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 121.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 142.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 220.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 119.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 161.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 142.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 235.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 194.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 152.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 154.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 144.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 140.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 167.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 172.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 206.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 183.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 150.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 157.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 156.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 147.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 143.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 146.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 181.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 193.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 196.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 201.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 153.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 159.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 149.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 67.117012 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 49.033722 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 59.705151 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 51.962601 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | 0.0787 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | 0.045399999999999996 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | 0.016453333333333334 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | 0.2891666666666667 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | 0.0038333333333333323 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | 0.015076666666666667 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | 0.0944 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | 0.1229 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | 0.09583333333333333 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.05863333333333332 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.07160000000000001 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.06823333333333333 |
| ID | GSE30365 |
| Title | Transcript Profiling of Arcuate Nucleus in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM753495 | 2Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.7655 |
| GSM753496 | 2Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.0328 |
| GSM753497 | 2Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: high;strain: Sprague-Dawley sample type: control | -0.1375 |
| GSM753498 | 2Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.7655 |
| GSM753499 | 2Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.585 |
| GSM753500 | 2Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 2Hz responder: no; strain: Sprague-Dawley sample type: control | -0.926 |
| GSM753501 | 100Hz_HR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 1.7226 |
| GSM753502 | 100Hz_HR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753503 | 100Hz_HR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: high;strain: Sprague-Dawley sample type: control | -0.5898 |
| GSM753504 | 100Hz_NR_Arc1 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -2.3646 |
| GSM753505 | 100Hz_NR_Arc2 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | 0.0 |
| GSM753506 | 100Hz_NR_Arc3 rat | strain: Sprague-Dawley electroacupuncture: 100Hz responder: no;strain: Sprague-Dawley sample type: control | -1.0704 |
| ID | GSE58803 |
| Title | Transcript Profiling of Periaqueductal Gray in Response to Electroacupuncture on Rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1419812 | 2Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.214957739 |
| GSM1419813 | 2Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.215036925 |
| GSM1419814 | 2Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | -0.202129841 |
| GSM1419815 | 2Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.09085792 |
| GSM1419816 | 2Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.022835464 |
| GSM1419817 | 2Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.380177482 |
| GSM1419818 | 2Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.112129292 |
| GSM1419819 | 2Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.111193355 |
| GSM1419820 | 2Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.024650648 |
| GSM1419821 | 100Hz_HR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.39007578 |
| GSM1419822 | 100Hz_HR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.784059166 |
| GSM1419823 | 100Hz_HR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419824 | 100Hz_HR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419825 | 100Hz_HR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419826 | 100Hz_NR_1h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419827 | 100Hz_NR_1h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419828 | 100Hz_NR_1h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.0 |
| GSM1419829 | 100Hz_NR_1h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.609034286 |
| GSM1419830 | 100Hz_NR_1h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 1h;strain: Sprague-Dawley treatment: control tissue: PAG | -2.101853213 |
| GSM1419831 | 2Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.045755236 |
| GSM1419832 | 2Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.149658143 |
| GSM1419833 | 2Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h; strain: Sprague-Dawley treatment: control tissue: PAG | 0.154317478 |
| GSM1419834 | 2Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.143833322 |
| GSM1419835 | 2Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.490976343 |
| GSM1419836 | 2Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.030128873 |
| GSM1419837 | 2Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.180486151 |
| GSM1419838 | 2Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.101269818 |
| GSM1419839 | 2Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.206457837 |
| GSM1419840 | 2Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 2Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.179784871 |
| GSM1419841 | 100Hz_HR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.191675084 |
| GSM1419842 | 100Hz_HR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.064457152 |
| GSM1419843 | 100Hz_HR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 0.770626029 |
| GSM1419844 | 100Hz_HR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -1.426598348 |
| GSM1419845 | 100Hz_HR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: high responder(HR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.371542459 |
| GSM1419846 | 100Hz_NR_24h_PAG1 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.730104403 |
| GSM1419847 | 100Hz_NR_24h_PAG2 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.836570465 |
| GSM1419848 | 100Hz_NR_24h_PAG3 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | 1.013904422 |
| GSM1419849 | 100Hz_NR_24h_PAG4 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.308771924 |
| GSM1419850 | 100Hz_NR_24h_PAG5 rat | strain: Sprague-Dawley tissue: PAG treatment: 100Hz electroacupuncture responder type: low responder(NR) time: 24h;strain: Sprague-Dawley treatment: control tissue: PAG | -0.403133273 |
